Übersichtsarbeit
Targeting p53 in Cancer
Current Medicinal Chemistry-Anti-Cancer Agents · 2001
DOI: 10.2174/1568011013354741 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Medicinal Chemistry-Anti-Cancer Agents, 2001. Verfasst von P Chène. Beteiligte Einrichtung: Novartis, Oncology Department, Basel CH-4002, Switzerland. patrick_chene@yahoo.com. Die Arbeit wurde bisher 22-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AdenoviridaeClinical Trials as TopicGene Expression Regulation, NeoplasticGenes, p53Genetic TherapyGenetic VectorsHumansImmunotherapyNeoplasmsRetroviridaeTumor Suppressor Protein p53
Substanzen
Tumor Suppressor Protein p53
Autor:innen und Institutionen
- Novartis, Oncology Department, Basel CH-4002, Switzerland. patrick_chene@yahoo.com
Zitieren
APA
Chène, P. (2001). Targeting p53 in Cancer. Current Medicinal Chemistry-Anti-Cancer Agents. https://doi.org/10.2174/1568011013354741
Vancouver
Chène P. Targeting p53 in Cancer. Current Medicinal Chemistry-Anti-Cancer Agents. 2001. doi:10.2174/1568011013354741
BibTeX
@article{Chne2001,
author = {Chène, P},
title = {Targeting p53 in Cancer},
journal = {Current Medicinal Chemistry-Anti-Cancer Agents},
year = {2001},
doi = {10.2174/1568011013354741}
}
EUVIMED